FIELD: medicine.
SUBSTANCE: invention relates to biomedicine (1-[(E)-[5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2R,3S,4R,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-ylidene]amino]guanidine, having structural formula:
as well as a method for production thereof. Method is realized by reaction of narperidin with aminoguanidine hydrochloride in an organic solvent in the presence of hydrochloric acid.
EFFECT: disclosed is a novel compound having good solubility in aqueous media combined with stability in a wide range of pH values and ability to trap various types of damaging agents, such as reactive oxygen species, reducing sugars, glyoxal and methylglyoxal.
3 cl, 6 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF | 2011 |
|
RU2606501C2 |
| SECONDARY MANNOSIS FOR BACTERIAL INFECTIONS TREATMENT | 2013 |
|
RU2667060C2 |
| IMMUNOMODULATORY AZALIDES BASED ON UREA | 2021 |
|
RU2811591C1 |
| MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2678327C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| CALICHEAMICIN DERIVATIVES AND THEIR ANTIBODY-DRUG CONJUGATES | 2018 |
|
RU2732568C1 |
| β-LACTAMS, METHOD FOR PREPARING INDICATED COMPOUNDS AND SERUM HYPOCHOLESTEROLEMIC AGENTS CONTAINING SUCH COMPOUNDS | 2002 |
|
RU2301799C2 |
| SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
| BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
| C-GLYCOSIDE DERIVATIVES CONTAINING A CONDENSED PHENYL RING, OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF PRODUCING SUCH AND A PHARMACEUTICAL COMPOSITION CONTAINING SUCH | 2017 |
|
RU2739024C2 |
